pharmaphorum

JANUARY 12, 2023

As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased. Drug diversion is the channelling of prescription drugs from a medical source into the illegal market.

Prescription 90

Prescription Healthcare Healthcare Medical 90

PM360

MAY 15, 2023

After a developmental day of shadowing a pharma sales rep, the fire was lite and she joined the sales team never looking back, ultimately landing her a role at ConnectiveRx in 2010. Laura has educated the new ConnectiveRx employees on the “real” patient journey. Interestingly, her approach was not only shaped by professional aptitude.

Sales 94

Sales Pharma sales reps Prescription Recruitment 94

Pharmaceutical Technology

JUNE 12, 2023

A leading CB2 agonist, olorinab, displayed encouraging results when managing abdominal pain in irritable bowel syndrome (IBS) patients, but failed to meet the primary efficacy endpoints. Currently, Jazz Pharmaceuticals’s nabiximols is the only cannabinoid approved for pain, receiving approval in Israel, in August 2010.

Medical 143

Medical Prescription Management Manufacturing 143

World of DTC Marketing

APRIL 7, 2021

I have to laugh when I hear that a pharma company is patient-centric because that’s become a slogan to make employees feel good about themselves while the costs of prescription drugs increase every year. Food and Drug Administration between 2010 and 2016 yet did taxpayers receive any discount?

Healthcare 162

Healthcare Healthcare Food and Drug Administration Pharma 162

PM360

FEBRUARY 1, 2024

The landscape is highly competitive with new prescription medications launching worldwide each year. Key stumbling blocks include payer activation and reimbursement hurdles, regulatory complexities, tepid market adoption by healthcare professionals (HCPs), field force inefficiencies, and obstacles in engaging and adopting patients.

Biopharma 59

Biopharma Competition Prescription Marketing 59

Pharmaceutical Technology

JUNE 29, 2022

Others judge its success based on the fact that 95% of rare diseases still have no available therapies and patient needs remain unmet. However, extended market exclusivity is often associated with high drug pricing and limited patient access. of the total patient population suffering from rare diseases. Approximately 10.9%

Food and Drug Administration 98

Food and Drug Administration Marketing FDA Pharmaceutical 98

World of DTC Marketing

DECEMBER 13, 2021

OPENING: American cancer patients spent more than $21 billion on their care in 2019. billion and patient time costs of $4.87 Some cancer patients may face out-of-pocket costs of nearly $12,000 a year for one drug. Many cancer patients without adequate insurance have only the starkest choice: your money or your life.

Food and Drug Administration 55

Food and Drug Administration Food Medical Medicine 55